Human-cl rhFVIII: Phase II started

In May, Octapharma began an open-label, U.S. and German Phase II trial to compare human-cl rhFVIII vs. Kogenate FS from Bayer AG (Xetra:BAY, Leverkusen, Germany) in 20 patients. ...